,Name_VH,Name_VL,Genbank_protein_id_vh,Genbank_protein_id_vl,Binds_to,Origin,VH,VL,Reference,Description_VH,Description_VL,Date_added
0,53181-1,5317-10,MZ517191,MZ517250,SARS-CoV-2,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYVLTWVRQAPGQGLEWMGWISAYNGSTNYAQNLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDPASYYDFWSGYVDYYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLFGNGYTYLNWYLQKPGQSPQLLIYLGSNRASGVPDRFSVSGSGTDFTLIISRVEAEDVGVYFCMQALQTPWTFGQGTKVEIK,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","Homo sapiens isolate 53181-1 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate 5317-10 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
1,5885-1,5885-13,OM001674,OM001699,SARS-CoV-2,Homo sapiens (human),QVQLQESGPGVVKPSETLSLTCSVSGGSISSTNYYWAWIRQPPGKGLEWIGSIFYTGSTYYNPSLKSRVIISVDTSKNQFSLRLTSVTAADTAVYYCARYTSYYDRSGFRRVEYFQHWGQGTLVTVSS,SYELTQPPSVSVSPGQTATITCSGDKLGDKYACWFQQKPGQSPVLVIYHDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWGSSTAVFGTGTKVTVL,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","Homo sapiens isolate 5885-1 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate 5885-13 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
2,CS1,CS99,OM457661,OM457822,SARS-CoV-2,Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFPFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDFQYVAATHSPYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGEGTKVEIK,"Reincke SM et al.; SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies; Science, eabm5835 (2022) In press; 2022.","Homo sapiens clone CS1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens clone CS99 anti-SARS-CoV-2 immunoglobulin kappa chain variable region mRNA, partial cds",2022-03-14
3,A10,A10,MZ927186,MZ927185,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYGDYRGLYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASRDINKYLAWYQQKPGKAPKLLIYGESSRAAGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone A10 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone A10 immunoglobulin light chain variable region gene, partial cds",2022-03-14
4,A11,A11,MZ927188,MZ927187,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSYGYLSGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone A11 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone A11 immunoglobulin light chain variable region gene, partial cds",2022-03-14
5,A12,A12,MZ927190,MZ927189,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGWGSLLNGIAVAGLDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone A12 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone A12 immunoglobulin light chain variable region gene, partial cds",2022-03-14
6,B2,B2,MZ927192,MZ927191,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDAYSGSYPYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASEGISNYLAWYQQKPGKAPKLLIYGTSDRASGIPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQYSAFPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone B2 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone B2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
7,B3,B3,MZ927194,MZ927193,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYTSPATIHWVRQAPGKGLEWMGGISPYKGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCAKDSYYYDSSGSGLGGGFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone B3 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone B3 immunoglobulin light chain variable region gene, partial cds",2022-03-14
8,B7,B7,MZ927196,MZ927195,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCAKDGWGSLLNGIAVAGLDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone B7 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone B7 immunoglobulin light chain variable region gene, partial cds",2022-03-14
9,B11,B11,MZ927198,MZ927197,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDAYPYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone B11 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone B11 immunoglobulin light chain variable region gene, partial cds",2022-03-14
10,C1,C1,MZ927200,MZ927199,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGISTQRGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYYGSGTYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQSIGSFLAWYQQKPGKAPKLLIYGESNRATGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQYNRYPWAFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone C1 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone C1 immunoglobulin light chain variable region gene, partial cds",2022-03-14
11,C2,C2,MZ927202,MZ927201,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKASGYTSPATIHWVRQAPGKGLEWMGGISPYKGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDAYSSSYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASEDISKYLAWYQQKPGKAPKLLIYGASNLHTGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone C2 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone C2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
12,C4,C4,MZ927204,MZ927203,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSGYDYGSVGRDYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone C4 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone C4 immunoglobulin light chain variable region gene, partial cds",2022-03-14
13,C7,C7,MZ927206,MZ927205,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTNYAIHWVRQAPGKGLEWMGGITPYNADTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGGNWAAPYSMDVWGNGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASHGISSYLAWYQQKPGKAPKLLIYDATIRATGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone C7 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone C7 immunoglobulin light chain variable region gene, partial cds",2022-03-14
14,D2,D2,MZ927208,MZ927207,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDARLLDYWGQGAQVTVSS,DIQMTQSPSSVSASVGDRVTITCRASRSIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone D2 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone D2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
15,D3,D3,MZ927210,MZ927209,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYSFADYAIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYDFWSGSYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQYSEYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone D3 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone D3 immunoglobulin light chain variable region gene, partial cds",2022-03-14
16,F1,F1,MZ927212,MZ927211,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYPFTSYAIHWVRQAPGKGLEWMGGITPYNADTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSSGYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone F1 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone F1 immunoglobulin light chain variable region gene, partial cds",2022-03-14
17,F5,F5,MZ927214,MZ927213,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYTFSNHAIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSGYVEGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQNIHSYLAWYQQKPGKAPKLLIYDTSKLQSGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYAAYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone F5 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone F5 immunoglobulin light chain variable region gene, partial cds",2022-03-14
18,F7,F7,MZ927216,MZ927215,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFSTYTIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSGYESSYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone F7 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone F7 immunoglobulin light chain variable region gene, partial cds",2022-03-14
19,G2,G2,MZ927218,MZ927217,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTANAIHWVRQAPGKGLEWMGGIGPGQGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGHCSGGSCPSGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYGASIRESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQYSAFPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone G2 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone G2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
20,G4,G4,MZ927220,MZ927219,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDHAIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYDFWSGSYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone G4 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone G4 immunoglobulin light chain variable region gene, partial cds",2022-03-14
21,G5,G5,MZ927222,MZ927221,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYSFTDHSIHWVRQAPGKGLEWMGGINPYTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSYGYLSGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDISHHLAWYQQKPGKAPKLLIYDASLRATGIPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYAAYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone G5 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone G5 immunoglobulin light chain variable region gene, partial cds",2022-03-14
22,G6,G6,MZ927224,MZ927223,SARS-CoV-2,synthetic construct,EVQLVESGAEVKKPGASVKVSCKVSGYTFSNHAIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYPGDYSGLDVWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQPISSYLAWYQQKPGKAPKLLIYEASKLQSGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone G6 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone G6 immunoglobulin light chain variable region gene, partial cds",2022-03-14
23,G12,G12,MZ927226,MZ927225,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYTFSNHAIHWVRQAPGKGLEWMGGINPNIGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYGDYRGLYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDIGNHLAWYQQKPGKAPKLLIYASSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone G12 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone G12 immunoglobulin light chain variable region gene, partial cds",2022-03-14
24,H2,H2,MZ927228,MZ927227,SARS-CoV-2,synthetic construct,EVQLVQSGAEVKKPGASVKVSCKVSGYPFTRSTIHWVRQAPGKGLEWMGGINAGTGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCARDGYSSGYYGMDVWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISDFLAWYQQKPGKAPKLLIYGASNRATGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCHQYATYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone H2 immunoglobulin heavy chain variable region gene, partial cds","Synthetic construct clone H2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
25,C1C-A3,C1C-A3,OL621229,OL621230,SARS-CoV-2,Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGTNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAYRDYVWRYFDLWGRGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKFGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQCRSNWPPGITFGQGTRLEIK,"Nabel,K.G. et al.; Structural basis for continued antibody evasion by the SARS-CoV-2 receptor-binding domain; Science (2022) In press; 2021.","Homo sapiens clone C1C-A3 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens clone C1C-A3 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
26,NaN,NaN,DQ168569,DQ168570,SARS-CoV,Homo sapiens (human),QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTV,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,"ter Meulen,J. et al.; Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants; PLoS Med. 3 (7), E237 (2006); 2006.","Homo sapiens anti-SARS-CoV immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens anti-SARS-CoV immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
27,WRAIR-2004,WRAIR-2196,MZ825529,MZ825470,not determined,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGRINPSSGGTNYAQKFQGRVTMTRDTSISTAYMELSSLRSDDTAVYYCATDGDDGENWFDPWGQGTLVIVSS,QPVLTQPSSVSVSPGQTATITCSGDVLAKKYARWFQQKPGQAPMLVIYKDTERPSGIPERFSGSSSGTTVTLTINGAQVEDEADYYCYSAAAWVFGGGTKLTVLG,"Krebs,S.J. et al.; Direct Submission; Submitted (16-AUG-2021) MHRP, HJF/WRAIR, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA; 2021.","Homo sapiens isolate WRAIR-2004 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate WRAIR-2196 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
28,AB007_VH,AB200_VL,OK094317,OK094392,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASPHCSSTSCLYHYYYYGMDVWGQGTTVTVSS,QSELTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSAYVVFGGGTKLTVL,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","Homo sapiens isolate ab007_VH immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate ab200_VL immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
29,12C10,12C10,MZ751047,MZ751048,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),EVKLQESGGGLVKPGGSLKLSCAASGFTFSNYSMSWVRQTPEKRLEWVATISNGGGYIYYLDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCGRPRPEKEFISTSTAMDHWGQGTTVT,EVTMSCKSSQSLLYSSYQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPFTFGSGTKLEIK,"Zhang,G. et al.; Epitope profiling reveals the critical antigenic determinants in SARSCoV-2 RBD-based antigen; Unpublished; 2021.","Mus musculus clone 12C10 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds","Mus musculus clone 12C10 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
30,CB6,CB6,MT470197,MT470196,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYCARVLPMYGDYLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK*,DIVMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECS*,"Shi,R. et al.; A potent human neutralizing monoclonal antibody targeting the receptor binding site of SARS-CoV-2 virus; Unpublished; 2020.","Homo sapiens clone CB6 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens clone CB6 anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
31,XG81,XG81,MZ668598,MZ668599,not determined,Homo sapiens (human),MEFGLSWIFLAAILKGVQCEVQLVESGGGLVKPGGSLRLSCAASGFSFSDAWMSWVRQAPGKGLEWVGRIKSKVDGGTTDYAAPVKGRFTISRDESKDILYLQMNSLKTEDTAVYFCATAVVVVVTNGLDDAFDIWGQGTMVTVSS,MRVPAQLLGLLLLWLRGARCDIQMTQSPSSLSASVGDRVTITCRASQSISSSLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSTLFTFGPGTKVDLK,"Xie,J. et al.; Direct Submission; Submitted (26-JUL-2021) The First Affiliated Hospital of USTC, University of Science and Technology of China, Lujiang Road 17, Hefei, Anhui 230001, China; 2021.","Homo sapiens isolate XG81 immunoglobulin heavy chain variable region gene, partial cds","Homo sapiens isolate XG81 immunoglobulin light chain variable region gene, partial cds",2022-03-14
32,XG83,XG83,MZ668600,MZ668601,not determined,Homo sapiens (human),MDWTWRFLFVVAAATGVQSQVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTITWVRQAPGQGLEWMGRVIPILGTANYAQKFQGRVTITADKSTRTAYMELSSLRSDDSAMYYCARERGYSGNGAAYYFDYWGQGTLVTVSS,MAWSPLLLTLLAHCTGSWAQSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADFYCQSYDSSLSTSIFGGGTKLTVL,"Xie,J. et al.; Direct Submission; Submitted (26-JUL-2021) The First Affiliated Hospital of USTC, University of Science and Technology of China, Lujiang Road 17, Hefei, Anhui 230001, China; 2021.","Homo sapiens isolate XG83 immunoglobulin heavy chain variable region gene, partial cds","Homo sapiens isolate XG83 immunoglobulin light chain variable region gene, partial cds",2022-03-14
33,CV503_VH,CV635_VL,MZ883076,MZ883093,"SARS-CoV-2, Spike protein",Homo sapiens (human),QVQLVQSGAEVKKPGSSVKVSCKASGGTFGISWVRQAPGQGLEWMGRIIPILGTANHAQKFQGRVTITADKSTGTVYMELSSLRSEDTAVYYCARDGDSGSYYETLGFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTIVTLTISGVQAEDEADYYCQSADSSATYVVFGGGTKLTVL,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","Homo sapiens clone CV503_VH immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens clone CV635_VL immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
34,H11B11,H11B11,MZ514138,MZ514137,SARS-CoV-2,synthetic construct,EVQLVESGGGLVQPGGSLRLSCAASGFTFIDYYMNWVRQAPGKGLEWVGFIRNKANDYTTEYSTSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHMYDDGFDFWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFEGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSPGK,DIQMTQSPSSLSASVGDRVTITCRASSSVRYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQWSYNPLTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECS,"Shi,R. et al.; A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants; Unpublished; 2021.","Synthetic construct clone h11B11 humanized ACE2-targeting immunoglobulin heavy chain gene, partial cds","Synthetic construct clone h11B11 humanized ACE2-targeting immunoglobulin light chain gene, partial cds",2022-03-14
35,COV2-2072,COV2-2072,MT665419,MT665032,"SARS-CoV-2, Spike protein",Homo sapiens (human),QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","Homo sapiens isolate COV2-2072 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate COV2-2072 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
36,COV2-2489,COV2-2489,MT665457,MT665070,"SARS-CoV-2, Spike protein",Homo sapiens (human),QLQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWGWIRQPPGKGLEWIASIYYSGSTYYNPSLKSRLTVSVDTSKNQFSLKLSSVTAADTAVYYCARQWKWFGEAWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFTFGGGTKVEIK,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","Homo sapiens isolate COV2-2489 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate COV2-2489 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
37,COV2-3012,COV2-3012,MT665458,MT665071,"SARS-CoV-2, Spike protein",Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDLHWVRQGTGKRLEWVSAIGTAGDTYYLGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVLYDSSGFYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYEIPPWTFGQGTKVEIK,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","Homo sapiens isolate COV2-3012 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate COV2-3012 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
38,COV2-2183,COV2-2183,MT665805,MT665418,"SARS-CoV-2, Spike protein",Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAGISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADTMVRGTYFEYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYCCSSYTSSRAVLFGGGTKLTVL,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","Homo sapiens isolate COV2-2183 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate COV2-2183 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
39,A19-46.1,A19-46.1,MZ458523,MZ458524,SARS-CoV-2,Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFTLSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGWAYWELLPDYYYGMDVWGQGTTVTVSS,QTVVTQEPSFSVSPGGTVTLTCGLSSGSVSTAYFPSWYQQTPGQAPRTLIYGTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGRGIVVFGGGTKLTVL,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","Homo sapiens isolate A19-46.1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate A19-46.1 anti-SARS-CoV-2 immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
40,A19-61.1,A19-61.1,MZ458525,MZ458526,SARS-CoV-2,Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAFHWVRQAPGKGLEWVAVISYDGSNQYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDLAIAVAGTWHYYNGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVIITCRASQGISSWLAWYQQKPGKAPKVLIYDASSLQSGVPSRFSGSGYGTDFTLTISSLQPEDSATYYCQQAKSFPITFGQGTRLEIK,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","Homo sapiens isolate A19-61.1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate A19-61.1 anti-SARS-CoV-2 immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
41,A23-58.1,A23-58.1,MZ458527,MZ458528,SARS-CoV-2,Homo sapiens (human),QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPNCSNVVCYDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYSASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGTSPWTFGQGTKVEIK,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","Homo sapiens isolate A23-58.1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate A23-58.1 anti-SARS-CoV-2 immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
42,B1-182.1,B1-182.1,MZ458529,MZ458530,SARS-CoV-2,Homo sapiens (human),QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCFDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGFPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPWTFGQGTKVEIR,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","Homo sapiens isolate B1-182.1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate B1-182.1 anti-SARS-CoV-2 immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
43,CC40.5-HC,CC9.3-KLC,MW426536,MW426544,"SARS-CoV-2, Spike protein",Homo sapiens (human),EVQLVESGGGVVQPGRSLRLSCVASGFTFSNYGMHWVRQAPGKGLEWVAVMSYDGSVTYYGDSVRGRFTISRDNSKNTLYLQMSSLRTDDTGVYYCAKGQPLDDIWGLGTLVTVSS,DIVMTQSPDSLAVSLGERASINCKSSQTISYISNNKNYLAWYQQKPGQPPRLLIYWASTRESGVPDRFSGGGFGTDFTLTISSLQAEDVAVYYCQQYFNTPWTFGQGTKVEIK,"Song,G. et al.; Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection; bioRxiv (2020); 2021.","Homo sapiens isolate CC40.5-HC cross-reactive anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate CC9.3-KLC cross-reactive anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
44,CC10.1-HC,CC40.7-LLC,MW532169,MW532198,"SARS-CoV-2, Spike protein",Homo sapiens (human),QLQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGKSPTVVTPWFDYWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDGDRPSGIPERFSGSNSGNTATLAISRVEAGDEADYYCQVWDSSSHWVFGGGTKLTVL,"Song,G. et al.; Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection; Unpublished; 2021.","Homo sapiens isolate CC10.1-HC cross-reactive anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate CC40.7-LLC cross-reactive anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
45,47D11,47D11,MW881223,MW881224,SARS-CoV-2,Homo sapiens (human),QVQLQESGPGLVKPSETLSLTCSVSGGSISSHYWSWIRQPPGKGLEWIGYIYYSGSTNHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGVLLWFGEPIFEIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYGASTRAPGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK,"Fedry,J. et al.; Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11; Sci Adv (2021) In press; 2021.","Homo sapiens clone 47D11 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens clone 47D11 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
46,CM17,CM58,MZ049539,MZ049552,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),QVQLVQSGAEVQKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFDPEDGETFYAQKFQGRVTMTEDSSTDTAYMELSSLGSEDTAVYYCATAAAVRGRGTIDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVVFGGGTKLTVL,"Voss,W.N. et al.; Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes; Science (2021) In press; 2021.","Homo sapiens isolate CM17 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate CM58 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
47,CA521,CA521,MW454371,MW454370,SARS-CoV-2,Homo sapiens (human),EVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEVNHSGSTNYNPSLKSRVTISVDTSKNQLSLKLNSVTAADTAVYYCARGNTMVRGVIIPFEYWDKGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEAAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,"Song,D. et al.; Structure and function analysis of a potent human neutralizing antibody CA521LALA against SARS-CoV-2; Unpublished; 2021.","Homo sapiens clone CA521 anti-SARS-CoV-2 immunoglobulin heavy chain mRNA, partial cds","Homo sapiens clone CA521 anti-SARS-CoV-2 immunoglobulin light chain mRNA, partial cds",2022-03-14
48,CV3-1,CV3-1,MW681558,MW681586,SARS-CoV-2,Homo sapiens (human),EVQLVESGPEVKKPGTSVKVPCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPSCSGGRCYDGFDIWGQGTMVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEXTARTAP,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","Homo sapiens isolate CV3-1 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate CV3-1 anti-SARS-CoV-2 immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
49,H2L2,H2L2,MW579767,MW579768,SARS-CoV,Homo sapiens (human),QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSDSAAWNWIRQSPSRGLEWLGRTYFRSKWNNHYAVSVKSRITINPDTSKNQFSLLLNPVTPEDTAVYYCARATLARGALDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNMNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGPGTDFTLTISSLQAEDVAVYYCQQYYSTPWTFGQGTKLEIK,"Wang,C. et al.; A conserved, immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies; Unpublished; 2021.","Homo sapiens strain H2L2 clone 1.6c7 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens strain H2L2 clone 1.6c7 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
50,H2L2,H2L2,MW579769,MW579770,SARS-CoV,Homo sapiens (human),QVQLQQSGPGLVKPSQTLSLTCAISGDNVFSNSAAWNWIRQSPSRGLEWLGRTYYRSKWNNDYAVSVKGRITINPDTYKNQFSLQLNPVTPEDTAVYFCARVPMNRGGMDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLASSNNMNYLAWYQQKPGQPPKLLIYWASIRESGVPDRFSGSGPGTDFTLTISSLQTEDVAVYYCHQYYSIPNTFGQGTKLEIK,"Wang,C. et al.; A conserved, immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies; Unpublished; 2021.","Homo sapiens strain H2L2 clone 28d9 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens strain H2L2 clone 28d9 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
51,H2L2,H2L2,MW579771,MW579772,SARS-CoV,Homo sapiens (human),QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSVAWNWIRQSPLRGLEWLGRTYYRSKWNNDYAVSVKSRIIITPDTSKNQFSLQLNPVTPEDTAVYYCARVGLGKGAFDIWGQGTMVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRPNKNNYLGWYQQKPGQPPKVLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSIPWTFGQGTKVEVK,"Wang,C. et al.; A conserved, immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies; Unpublished; 2021.","Homo sapiens strain H2L2 clone 18h2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens strain H2L2 clone 18h2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
52,11A,1A,MT943491,MT943518,not determined,Homo sapiens (human),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGPDILTGYYNYYYYGMDVWGQGTMVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDQGVFGGGTKLTVL,"Huang,K.-Y.A. et al.; Direct Submission; Submitted (28-AUG-2020) Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, No. 5, Fu-Shin street, Kweishan, Taoyuan 333, Taiwan; 2021.","Homo sapiens clone FD 11A heavy chain variable region mRNA, partial cds","Homo sapiens clone FM 1A light chain variable region mRNA, partial cds",2022-03-14
53,COVA2-15,COVA2-15,MT599861,MT599945,SARS-CoV-2,Homo sapiens (human),QVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWASAISGSGGSTYYADSVEGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDTGYCGDDCYIKLIRGGPDYWGQGTLVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTFLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPRTFGQGTKLEIK,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","Homo sapiens isolate COVA2-15 anti-SARS-CoV-2 monoclonal antibody heavy chain variable region mRNA, partial cds","Homo sapiens isolate COVA2-15 anti-SARS-CoV-2 monoclonal antibody light chain variable region mRNA, partial cds",2022-03-14
54,COVA1-16,COVA1-16,MT599835,MT599919,SARS-CoV-2,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINSSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPPRNYYDRSGYYQRAEYFQHWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQRPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNPPLTFGGGTKLEIK,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","Homo sapiens isolate COVA1-16 anti-SARS-CoV-2 monoclonal antibody heavy chain variable region mRNA, partial cds","Homo sapiens isolate COVA1-16 anti-SARS-CoV-2 monoclonal antibody light chain variable region mRNA, partial cds",2022-03-14
55,BALB/C,BALB/C,MW271801,MW271802,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),EVQLQESGPSLVKPSQTLSLTCSVTGDSITNGYWNWIRKFPGNKLEYMGYISYSGSTYYSPSLKSRISITRDTSKNQHYLQLNSVTSEDTATYYCASDYHGSKYYFDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGHRVSITCKASQDVGNDVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYNRYPYTFGGGTKLEIK,"Zhang,C. et al.; Direct Submission; Submitted (15-NOV-2020) Unit of Vaccinology & Antiviral Strategies, Institut Pasteur of Shanghai, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; 2020.","Mus musculus strain BALB/c clone 3C1 anti-SARS-CoV-2 RBD immunoglobulin gamma heavy chain variable region mRNA, partial cds","Mus musculus strain BALB/c clone 3C1 anti-SARS-CoV-2 RBD immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
56,BALB/C,BALB/C,MW271803,MW271804,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),QVQLKQSGPSLVQPSQSLSITCTVSGFSLTSYGVHWVRQSPGKGLEWLGVMWRGGNTDYNAAFMSRLSITKDNSKSQVFFKMNSLQTDDTAIYYCAKNGGAHAMDFWGQGTSVTVSS,NIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFLHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPFTFGSGTKLEIK,"Zhang,C. et al.; Direct Submission; Submitted (15-NOV-2020) Unit of Vaccinology & Antiviral Strategies, Institut Pasteur of Shanghai, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; 2020.","Mus musculus strain BALB/c clone 2H2 anti-SARS-CoV-2 RBD immunoglobulin gamma heavy chain variable region mRNA, partial cds","Mus musculus strain BALB/c clone 2H2 anti-SARS-CoV-2 RBD immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
57,JS16,JS01,MW116210,MW116179,SARS-CoV-2,Homo sapiens (human),QVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARAYWGRGPTIFGVVSNTTRYYGMDVWGQGTTVTVSS,ENVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRGVTFGPGTKVDIK,"Zhang,L. et al.; Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis; Front Immunol 11, 595970 (2020); 2021.","Homo sapiens clone JS16 anti-SARS-CoV-2 nucleocapsid monoclonal antibody heavy chain variable region gene, partial cds","Homo sapiens clone JS01 anti-SARS-CoV-2 nucleocapsid monoclonal antibody kappa chain variable region gene, partial cds",2022-03-14
58,MAB362,MAB362,MT789771,MT789772,"SARS-CoV-2, Spike protein",Homo sapiens (human),QVQLVESGGGVVQPGRSLRLSCAASGFSFSSYGMHWVRQAPGKGLEWVAVIWYDGSDKYYADSVKGRFTISRDNSKNTLYLQLNSLRAEDTAIYYCARERYFDWIFDFWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSWTFGQGTKVEIK,"Wang,Y. et al.; IgA MAb blocks SARS-CoV-2 spike-ACE2 interaction providing mucosal immunity; Nat Commun (2020) In press; 2020.","Homo sapiens MAb362 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens MAb362 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
59,4-8,2-17,MT712278,MT712315,"SARS-CoV-2, Spike protein",Homo sapiens (human),QVQLVQSGAEVKKAGSSVKVSCKASGGTFSSHTITWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCASLQTVDTAIEKYYGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSDLAWYQHKPGQAPRLLIYGASTRATGIPVRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPFTFGGGTKVEIK,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","Homo sapiens isolate 4-8 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate 2-17 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
60,COV2-2196,COV2-2196,MT763531,MT763532,"SARS-CoV-2, Spike protein",Homo sapiens (human),QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; Nat. Med. (2020) In press; 2020.","Homo sapiens isolate COV2-2196 anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate COV2-2196 anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
61,MCOV.2.1H10.G,MCOV.2.1H06.K,MT341590,MT341641,not determined,Mus musculus (house mouse),QVQLKESGPGLVAPSQSLSITCTVSGFSLTNYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARISYYDYEGVDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCRASESVEYYGTSLMQWFQQKPGQPPKLLIFAASNVESGVPARFGGSGSGTDFSLNIHPVEEDDIATYFCQQSRKVPWTFGGGTKLEIK,"Ellebedy,A.H. et al.; Direct Submission; Submitted (14-APR-2020) Pathology, Washington University St. Louis, 425 South Euclid, St. Louis, MO 63110, USA; 2020.","Mus musculus isolate mCOV.2.1H10.G immunoglobulin heavy chain variable region mRNA, partial cds","Mus musculus isolate mCOV.2.1H06.K immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
62,CC12.1-HC,CC6.33-KC,MT594038,MT594103,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSLWTFGQGTKLEIK,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","Homo sapiens isolate CC12.1-HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate CC6.33-KC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",2022-03-14
63,ADI-55688_HC,ADI-56081_LC,MT565750,MT566149,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYYMNWVRQAPGKGLEWVSSISSDGYNTYYPDSLKGRFTISRDSAKNSLYLQMNSLRADDTAVYYCARDFSGHTAVAGTGFEYWGQGTLVTVSS,ETTLTQSPGTLSLSPGERATLSCRASQSVTSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRAPLYTFGLGTKVDIK,"Walker,L.M. et al.; Direct Submission; Submitted (03-JUN-2020) Antibody Sciences, ADIMAB LLC, 7 LUCENT DRIVE, Lebanon, NH 03766, United States; 2020.","Homo sapiens isolate ADI-55688_HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds","Homo sapiens isolate ADI-56081_LC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
64,S1,NaN,OL743524,NaN,SARS-CoV-2,synthetic construct,SGGGLQTPGGGLGLVCKAPGFSIGGYIMHWVRQTPGKGLEYVAGIDAGGGVTWYGAAVKGRATISRDNGQSTVRLQLNDLRAEDTGIYYCARSTGSDYYDWNYAGEIGAWGHGTEVIVSSGGGGSGGGGSGGGGSALTQPSSVSANPGETVKITCSGGGSSSYYGWYQQKSPGGAPVTVIYSNTGRPSDIPSRFSGSKSGSTHTLTITGVQVDDEAVYYCGSEDSSTHDGIFGAGTTLTVLG,NaN,"Ge,S. et al.; Specific anti-SARS-CoV-2 S1 IgY-scFv is promising tools for COVID-19 diagnosis and treatment; Unpublished; 2021.","Synthetic construct anti-SARS-CoV-2 S1 scFv antibody gene, partial cds",NaN,2022-03-14
65,SDAB-1E2,NaN,MT813428,NaN,"SARS-CoV-2, Spike protein",synthetic construct,QVQLVESGGGLVQPGGSLRLSCAASGADAFVIIGGWFRQAPGKGLEAVAAIAWTDQHEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAQDSAYIKSKGSRAYEYWGQGTQVTVSS,NaN,"Yang,W. et al.; Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor-Binding Domain; Unpublished; 2020.","Synthetic construct anti-SARS-CoV-2 nanobody sdAb-1E2 gene, partial cds",NaN,2022-03-14
66,SDAB-5F8,NaN,MT813432,NaN,"SARS-CoV-2, Spike protein",synthetic construct,QVQLVESGGGLVQPGGSLRLSCAASGRQAVVFGWFRQAPGKGLEAVAAIHVPAKNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAHYEFNDFVWQGYSSDYWGQGTQVTVSS,NaN,"Yang,W. et al.; Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor-Binding Domain; Unpublished; 2020.","Synthetic construct anti-SARS-CoV-2 nanobody sdAb-5F8 gene, partial cds",NaN,2022-03-14
